Laboratory of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
Department of Molecular Genetics, Brain Research Institute, Niigata University, Niigata, Japan.
Neurosci Res. 2023 Aug;193:63-70. doi: 10.1016/j.neures.2023.03.002. Epub 2023 Mar 24.
Extracellular tau has been highlighted in the pathogenesis of Alzheimer disease (AD), which is the most common neurodegenerative disease. Pathological analyses as well as model animal studies suggest that amyloid-β peptide (Aβ) deposition facilitates the spreading of tau aggregation pathology via extracellular tau. However, the precise mechanism of tau secretion remains unknown. Here, we show that the overexpression of amyloid precursor protein (APP) enhances the secretion of tau phosphorylated at threonine 181 in mouse neuroblastoma Neuro2a cells. Moreover, we found that soluble amyloid precursor protein β (sAPPβ), which is generated by β-site APP cleaving enzyme 1 (BACE1), mediates tau secretion. Our results demonstrate that BACE1-mediated cleavage of APP plays pathological roles in AD pathogenesis by not only Aβ production, but by the spreading of tau aggregation pathology via sAPPβ in AD patients.
细胞外 tau 蛋白在阿尔茨海默病(AD)的发病机制中受到了关注,AD 是最常见的神经退行性疾病。病理分析和模型动物研究表明,淀粉样β肽(Aβ)沉积通过细胞外 tau 促进 tau 聚集病理的传播。然而,tau 分泌的确切机制仍不清楚。在这里,我们发现淀粉样前体蛋白(APP)的过表达增强了在小鼠神经母细胞瘤 Neuro2a 细胞中磷酸化的 tau 第 181 位苏氨酸的分泌。此外,我们发现可溶性淀粉样前体蛋白β(sAPPβ),由β-位点 APP 裂解酶 1(BACE1)产生,介导 tau 的分泌。我们的结果表明,BACE1 介导的 APP 裂解通过 sAPPβ 在 AD 患者中传播 tau 聚集病理,不仅在 Aβ产生方面,而且在 AD 发病机制中发挥病理性作用。